Gestational Diabetes Mellitus

University Hospitals

G. Rao, C. Nau

ACC 2023: SGLT2i Use - Dos and Don'ts

ACC 2023 Conference Coverage

A. Armbruster

Coronary CTA for Assessing CAD - Are We There Yet?

Matthew Budoff

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

University of Colorado Department of Medicine

R. Johnson

Weightloss in Menopause

Susan Brian

The Deadly Paradox: Current Practice, Driven by Guidelines, Is Not A…

Michael Makover

Exercise, Weight Loss, and Breast Cancer Risk: The Importance of BMI

Cleveland Clinic Taussig Cancer Institute

A. Guthrie

Updates in Inpatient Stroke Care

OHSU

A. Treister

The Differences Between the Products of GLP1's and GLP/GIPs

Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

Susan Brian

"Pill in Pocket" Anticoagulation for Atrial Fibrillation: Fact, Fict…

Houston Methodist DeBakey Heart and Vascular Center

R. Passman

Vitamin D Deficiency

Keck School of Medicine of USC

V. Gevorgyan

Obesity and Heart Health: Weighing the Facts

The North American Thrombosis Forum (NATF)

K. D. Palmer Emrich

Endoscopic Weight Loss Therapies - A Paradigm Shift in the Treatment…

Houston Methodist

T. R. Mccarty

Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin

ACC 2024 Insights: A Plant-Based Diet

ACC 2024 Insights

N. Barnard

Switch, Change, Rearrange: Diabetes Medication Transitions, De-presc…

Jennifer Rosselli

S. Twillmann

The Best of AHA23 for the Primary Care Doctor

Cecilia Bahit

New Research: Side Effect of GLP1

Susan Brian